PROTACs和粘合剂:工程癌症治疗的惊人前景 À La Carte
Jean-Marc Ferrero1, Jocelyn Gal2, Baharia Mograbi3
1Department of Medical Oncology, Antoine Lacassagne Center, University Côte d'Azur, 33 Avenue de Valombrose, 06189 Nice, France.
Pharmaceuticals (Basel, Switzerland)
|September 27, 2025
概括
化向化体 (PROTACs) 和分子提供了消除致病蛋白质的新方法. 人工智能加速了这些向蛋白质降解剂的开发,用于个性化癌症治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 向蛋白质溶解的嵌合体 (PROTACs) 和分子是双功能分子,可诱导向蛋白质的选择性降解.
- 这些方法对于在癌症治疗中准以前无法治疗的蛋白质至关重要.
- 无论是PROTAC还是分子糊,都旨在消除与疾病相关的蛋白质,提供一种新的治疗策略.
研究的目的:
- 突出PROTACs和分子粘剂在克服癌症治疗方面的挑战方面的潜力.
- 强调人工智能 (AI) 在加速发现和优化向蛋白质降解剂方面的作用.
- 探索这些进展对个性化瘤学和分子瘤板的影响.
主要方法:
- 利用人工智能加速发现和优化选择性蛋白质结合剂.
- 使用PROTAC和分子粘剂来诱导向蛋白质降解.
- 开发策略,以准癌症中以前无法获得的分子通路.
主要成果:
- 人工智能显著简化了强效和选择性蛋白质降解剂的开发.
- PROTACs和分子粘剂显示出完全消除疾病相关蛋白质的能力.
- 针对与癌症相关的多种分子通路开辟了新的治疗途径.
结论:
- 在个性化瘤学中,PROTACs和分子粘剂代表了转化剂.
- 人工智能集成加速了向蛋白质降解剂的开发和治疗潜力.
- 这些进展为癌症护理中快速,针对患者的治疗决策铺平了道路.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K

![Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=50)
